ID   GB-val4
AC   CVCL_XZ67
DR   cancercelllines; CVCL_XZ67
DR   Wikidata; Q93558992
RX   PubMed=31388924;
CC   Doubling time: 22 hours (PubMed=31388924).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=31388924).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305Arg (c.914A>G); Zygosity=Unspecified (PubMed=31388924).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=31388924
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D21S11: 30,31
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
RX   PubMed=31388924; DOI=10.1007/s13577-019-00267-z;
RA   Munoz-Hidalgo L., San-Miguel T., Megias J., Gil-Benso R.,
RA   Cerda-Nicolas M., Lopez-Gines C.;
RT   "Characterization of a new glioblastoma cell line, GB-val4, with
RT   unusual TP53 mutation.";
RL   Hum. Cell 32:557-567(2019).
//